Alpha Tau Medical, Samsung Medical Center Sign MoU for Pancreatic Cancer Clinical Trial in South Korea

MT newswire2026/10/22 13:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:22 AM EDT, 10/22/2026 (MT Newswires) -- Alpha Tau Medical (DRTS) and Samsung Medical Center have signed a memorandum of understanding for a potential clinical trial related to pancreatic cancer patients in South Korea, the company said Thursday. Any such trial will be subject to regulatory and ethics committee approvals, according to a statement.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alpha Tau Medical, Samsung Medical Center Sign MoU for Pancreatic Cancer Clinical Trial in South Korea

You may also like

Crypto prices